REGEnLIFE
PrivateLast Round
Series A
May 9, 2023
Total Funding Raised
$6.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
REGEnLIFE is a therapeutic devices company that develops a non-invasive medical device designed to alter the progression of neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
REGEnLIFE Comparables
Compare REGEnLIFE with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuroEM Therapeutics | 81% | |
| Neurocia SAS | 80% | |
| Cognito Therapeutics | 79% | |
REGEnLIFE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 9, 2023 | ||||
| Seed | Jul 10, 2019 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 52% MoM.
- Dec 1, 2025
Monthly visitors increased 2990% from 21 to 649.
REGEnLIFE Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about REGEnLIFE's valuation, stock price, and market status.